MaingayoneCAS# 271585-66-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 271585-66-1 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Oil |
Formula | C42H52O9 | M.Wt | 700.9 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Maingayone Dilution Calculator
Maingayone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.4267 mL | 7.1337 mL | 14.2674 mL | 28.5347 mL | 35.6684 mL |
5 mM | 0.2853 mL | 1.4267 mL | 2.8535 mL | 5.7069 mL | 7.1337 mL |
10 mM | 0.1427 mL | 0.7134 mL | 1.4267 mL | 2.8535 mL | 3.5668 mL |
50 mM | 0.0285 mL | 0.1427 mL | 0.2853 mL | 0.5707 mL | 0.7134 mL |
100 mM | 0.0143 mL | 0.0713 mL | 0.1427 mL | 0.2853 mL | 0.3567 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Physcion 8-O-(6′-methylmalonyl)-glucopyranoside
Catalog No.:BCN0989
CAS No.:1345826-33-6
- Emodin 8-O-(6′-methylmalonyl)-glucopyranoside
Catalog No.:BCN0988
CAS No.:928262-58-2
- 2,3,5,4'-tetrahydroxystilbene-2-O-(2''-O-feruloyl)-β-D-glucopyranoside
Catalog No.:BCN0987
CAS No.:359406-98-7
- Chrysophanol-8-O-β-D-(6′-O-malonyl)glucoside
Catalog No.:BCN0986
CAS No.:205107-13-7
- Morin-3-O-glucopyranoside
Catalog No.:BCN0985
CAS No.:1169766-14-6
- Delphinidin 3-O-[6''-O-(Z)-coumaroylrutinoside]-5-O-glucoside
Catalog No.:BCN0984
CAS No.:207514-92-9
- Delphinidin 3-Rutinoside(Cis-p-coumarin)-5-glucoside
Catalog No.:BCN0983
CAS No.:28463-30-1
- Petunidin 3-(p-coumaroylrutinoside)-5- glucoside
Catalog No.:BCN0982
CAS No.:30678-24-1
- Pelargonidin 3-O-[6-O-(E)-Ferulyl-2-O-{6-O-(E)-P-coumarin-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl)-β-D-glucoside
Catalog No.:BCN0981
CAS No.:1333206-60-2
- Pelargonidin 3-O-[6-O-(E)-Ferulyl-2-O-{6-O-(E)-Ferulyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl)-β-D-glucoside
Catalog No.:BCN0980
CAS No.:925673-36-5
- Pelargonidin 3-O-[6-O-(E)-Ferulyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl)-β-D-glucoside
Catalog No.:BCN0979
CAS No.:1333206-58-8
- Pelargonidin 3-O-[6-O-(E)-P-coumarin-2-O-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl)-β-D-glucoside
Catalog No.:BCN0978
CAS No.:218963-76-9
- Giganteone A
Catalog No.:BCN0991
CAS No.:460337-13-7
- Maingayone B
Catalog No.:BCN0992
CAS No.:1071223-57-8
- Kaempferol 3,5-O-diglucoside
Catalog No.:BCN0993
CAS No.:205103-97-5
- Oxytroflavoside F
Catalog No.:BCN0994
CAS No.:1391144-85-6
- Oxytroflavoside D
Catalog No.:BCN0995
CAS No.:1391144-83-4
- Benzylpropyl acetate
Catalog No.:BCN0996
CAS No.:7492-40-2
- trans-Cinnamoyl beta-D-glucoside
Catalog No.:BCN0997
CAS No.:13080-39-2
- Cagayanin
Catalog No.:BCN0998
CAS No.:99096-51-2
- Giganteone C
Catalog No.:BCN0999
CAS No.:1071223-56-7
- Isorhamnetin 3,5-O-diglucoside
Catalog No.:BCN1000
CAS No.:2035413-03-5
- (R)-Mucronulatol
Catalog No.:BCN9004
CAS No.:57128-11-7
- Quercetin 3,5-O-diglucoside
Catalog No.:BCX0001
CAS No.:206257-35-4
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting alpha-glucosidase and free radicals.[Pubmed:26343830]
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4529-33.
In search of effective antidiabetic agents having therapeutic effect by inhibiting alpha-glucosidase and preventive effect by scavenging free radicals, Horsfieldia macrobotrys showed promising bioactivity required for the proposed criteria. Bioassay-guided isolation of the stem bark extract resulted in two new arylalkanones named horsfieldone A (1) and Maingayone D (2), together with a new flavanone C-glucoside named 8-C-beta-d-glucopyranosylpinocembrin (3). Their structures and stereochemistry were determined by spectroscopic techniques as well as Mosher's method. Of isolated compounds, Maingayone D (2) was the most potent inhibitors against both alpha-glucosidases and free radicals. The presence of additional phenolic moieties in 2 clearly indicated their critical roles in inhibitory effects. Further investigation on mechanism underlying alpha-glucosidase inhibition indicated that Maingayone D (2) could retard the enzyme function by both competitive and noncompetitive manners.